BEMRIST
LIVE

Serial Number

79227117

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Jan 11, 2018

Add to watchlist:

No watchlists yet
View on USPTO

BEMRIST Trademark

Serial Number: 79227117 • Registration: 5537945

BEMRIST is a trademark filed by Novartis AG on January 11, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

January 11, 2018

Registration Date

August 14, 2018

Published for Opposition

May 29, 2018

Cancellation Date

February 28, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
May 20, 2026 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
May 19, 2026 INNA
GENERIC MADRID TRANSACTION CREATED
May 19, 2026 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 28, 2025 INTR
CANCELLED SECTION 71
Feb 28, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 14, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2018 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 1, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 14, 2018 FICR
NOTIFICATION PROCESSED BY IB
Sep 21, 2018 GPNX
REGISTERED-PRINCIPAL REGISTER
Aug 14, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 29, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 16, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 16, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2018 CRFA
ASSIGNED TO LIE
Apr 19, 2018 ALIE
REFUSAL PROCESSED BY IB
Apr 13, 2018 RFNT
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 3, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 3, 2018 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 15, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 15, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 9, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 8, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 3, 2018 MAFR
ASSIGNED TO EXAMINER
Feb 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 20, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 15, 2018 SDRC